CV

Creacion Ventures

North America, Massachusetts, United States, Boston

Description

Creacion Ventures is a venture capital firm, focus on investment within the healthcare industry, particularly biopharma space.

Investor Profile

Creacion Ventures has backed more than 10 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Biotechnology, Therapeutics, Health Care.

Stage Focus

  • Series B (50%)
  • Series A (40%)
  • Series C (10%)

Country Focus

  • United States (90%)
  • China (10%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Oncology
  • Medical
  • Pharmaceutical
  • Health Diagnostics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Creacion Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 6
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 5
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 3
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 3
Colt Ventures
North America, Texas, United States, Dallas
Co-Investments: 3
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 2

What are some of recent deals done by Creacion Ventures?

Sirius Therapeutics

San Diego, California, United States

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BMay 9, 2025
Amount Raised: $50,000,000
Odyssey Therapeutics

Cambridge, Massachusetts, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

BiotechnologyHealth CareOncologyTherapeutics
Series CDec 5, 2023
Amount Raised: $101,000,000
Sirius Therapeutics

San Diego, California, United States

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BOct 9, 2023
Amount Raised: $60,000,000
Odyssey Therapeutics

Cambridge, Massachusetts, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

BiotechnologyHealth CareOncologyTherapeutics
Series BOct 13, 2022
Amount Raised: $168,000,000
Frontera Therapeutics

Bedford, Massachusetts, United States

Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.

Biotechnology
Series BJun 24, 2022
Amount Raised: $160,000,000
MOMA Therapeutics

Cambridge, Massachusetts, United States

MOMA Therapeutics operates as a biotechnology company.

BiotechnologyMedicalTherapeutics
Series BMay 10, 2022
Amount Raised: $150,000,000
Odyssey Therapeutics

Cambridge, Massachusetts, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

BiotechnologyHealth CareOncologyTherapeutics
Series ADec 7, 2021
Amount Raised: $218,000,000
Parthenon Therapeutics

Cambridge, Massachusetts, United States

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

BiotechnologyLife ScienceTherapeutics
Series ANov 3, 2021
Amount Raised: $65,000,000
Pediatrix Therapeutics

Xuhui, Shanghai, China

Pediatrix Therapeutics is a developer of children's pharmaceuticals, drugs and medicine.

Health CareHealth DiagnosticsTherapeutics
Series AApr 28, 2021
MOMA Therapeutics

Cambridge, Massachusetts, United States

MOMA Therapeutics operates as a biotechnology company.

BiotechnologyMedicalTherapeutics
Series AApr 16, 2020
Amount Raised: $86,000,000